SPAC Overview
$690M
IPO Size
$693M
Trust (as of 2022-09-30)
Failed
Current Status
2021
IPO Year
Timeline Progress
About
Longview Acquisition Corp. II is a blank-check company seeking an initial business combination with an established business, with a particular emphasis on healthcare and broader sector interests.
Investment Focus
Healthcare, Industrial, Consumer, Media, Technology, IT Services
The terms and the filing trail behind Longview Acquisition Corp. II
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Sponsors
Leadership
Underwriters
Extended Team Information
Led by Chairman Larry Robbins, CEO John Rodin and CFO Mark Horowitz, supported by director nominees Westley Moore, Shalinee Sharma and Brian Zied. Team backgrounds include Glenview investment experience, public-company engagement, operating, investment banking, financial, and nonprofit leadership.
Key Information
IPO Date
March 22, 2021
Total Redemptions
$613M
State of Incorporation
DE
SIC
6770
Failed Date
January 9, 2023
SPAC Ticker
LGV